Publication | Open Access
Impact of Hepatitis C Virus (HCV) Genotypes on Quantification of HCV RNA in Serum by COBAS AmpliPrep/COBAS TaqMan HCV Test, Abbott Antiretroviral Therapy HCV RealTime Assay, and VERSANT HCV RNA Assay
24
Citations
13
References
2007
Year
Diagnostic VirologyHepatologyHepatitis CHepatitis C VirusViral HepatitisMedicineMean Titer DifferencesRna ValuesAntiviral TherapyHepatitisVirologyHcv RnaNucleic Acid Amplification TestViral DiagnosticsChronic Viral InfectionMolecular DiagnosticsClinical SpecimensEpidemiology
The VERSANT HCV RNA 3.0 (bDNA), COBAS AmpliPrep/COBAS TaqMan HCV, and Abbott ART HCV RealTime assays were compared for hepatitis C virus RNA quantification in 158 clinical specimens (genotypes 1 to 5). RNA values differed significantly between methods (P < 0.0001), and mean titer differences ranged from 0.01 to 0.50 log(10) IU/ml depending on the genotypes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1